BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29735270)

  • 21. Muscle hypertrophy as the presenting sign in a patient with a complete FHL1 deletion.
    Willis TA; Wood CL; Hudson J; Polvikoski T; Barresi R; Lochmüller H; Bushby K; Straub V
    Clin Genet; 2016 Aug; 90(2):166-70. PubMed ID: 27409453
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Familial reducing body myopathy with cytoplasmic bodies and rigid spine revisited: identification of a second LIM domain mutation in FHL1.
    Schessl J; Columbus A; Hu Y; Zou Y; Voit T; Goebel HH; Bönnemann CG
    Neuropediatrics; 2010 Feb; 41(1):43-6. PubMed ID: 20571991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four and a half LIM domains protein 1 can be as a double-edged sword in cancer progression.
    Wei X; Zhang H
    Cancer Biol Med; 2020 May; 17(2):270-281. PubMed ID: 32587768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of FHL1 as a regulator of skeletal muscle mass: implications for human myopathy.
    Cowling BS; McGrath MJ; Nguyen MA; Cottle DL; Kee AJ; Brown S; Schessl J; Zou Y; Joya J; Bönnemann CG; Hardeman EC; Mitchell CA
    J Cell Biol; 2008 Dec; 183(6):1033-48. PubMed ID: 19075112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genes, proteins and complexes: the multifaceted nature of FHL family proteins in diverse tissues.
    Shathasivam T; Kislinger T; Gramolini AO
    J Cell Mol Med; 2010 Dec; 14(12):2702-20. PubMed ID: 20874719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. X-linked Recessive Distal Myopathy With Hypertrophic Cardiomyopathy Caused by a Novel Mutation in the FHL1 Gene.
    D'Arcy C; Kanellakis V; Forbes R; Wilding B; McGrath M; Howell K; Ryan M; McLean C
    J Child Neurol; 2015 Aug; 30(9):1211-7. PubMed ID: 25246303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FHL1-mutated reducing body myopathy.
    Lim KY; Kim HH; Sung JJ; Oh BM; Kim K; Park SH
    Neuropathology; 2020 Apr; 40(2):185-190. PubMed ID: 31803991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mutation in FHL1 in a family with X-linked scapuloperoneal myopathy: phenotypic spectrum and structural study of FHL1 mutations.
    Chen DH; Raskind WH; Parson WW; Sonnen JA; Vu T; Zheng Y; Matsushita M; Wolff J; Lipe H; Bird TD
    J Neurol Sci; 2010 Sep; 296(1-2):22-9. PubMed ID: 20633900
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.
    Albrecht I; Wick C; Hallgren Å; Tjärnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo LM; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kämpe O; Lundberg IE
    J Clin Invest; 2015 Dec; 125(12):4612-24. PubMed ID: 26551678
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Muscle MRI in FHL1-linked reducing body myopathy.
    Astrea G; Schessl J; Clement E; Tosetti M; Mercuri E; Rutherford M; Cioni G; Bönnemann CG; Muntoni F; Battini R
    Neuromuscul Disord; 2009 Oct; 19(10):689-91. PubMed ID: 19616434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proteomic characterization of aggregate components in an intrafamilial variable FHL1-associated myopathy.
    Feldkirchner S; Walter MC; Müller S; Kubny C; Krause S; Kress W; Hanisch FG; Schoser B; Schessl J
    Neuromuscul Disord; 2013 May; 23(5):418-26. PubMed ID: 23489660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reducing bodies and myofibrillar myopathy features in FHL1 muscular dystrophy.
    Selcen D; Bromberg MB; Chin SS; Engel AG
    Neurology; 2011 Nov; 77(22):1951-9. PubMed ID: 22094483
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Zebrafish fhl1A in Satellite Cell and Skeletal Muscle Development.
    Chen F; Yuan W; Mo X; Zhuang J; Wang Y; Chen J; Jiang Z; Zhu X; Zeng Q; Wan Y; Li F; Shi Y; Cao L; Fan X; Luo S; Ye X; Chen Y; Dai G; Gao J; Wang X; Xie H; Zhu P; Li Y; Wu X
    Curr Mol Med; 2017; 17(9):627-636. PubMed ID: 29521230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proteomic identification of FHL1 as the protein mutated in human reducing body myopathy.
    Schessl J; Zou Y; McGrath MJ; Cowling BS; Maiti B; Chin SS; Sewry C; Battini R; Hu Y; Cottle DL; Rosenblatt M; Spruce L; Ganguly A; Kirschner J; Judkins AR; Golden JA; Goebel HH; Muntoni F; Flanigan KM; Mitchell CA; Bönnemann CG
    J Clin Invest; 2008 Mar; 118(3):904-12. PubMed ID: 18274675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel single nucleotide splice site mutation in FHL1 confirms an Emery-Dreifuss plus phenotype with pulmonary artery hypoplasia and facial dysmorphology.
    Pen AE; Nyegaard M; Fang M; Jiang H; Christensen R; Mølgaard H; Andersen H; Ulhøi BP; Østergaard JR; Væth S; Sommerlund M; de Brouwer AP; Zhang X; Jensen UB
    Eur J Med Genet; 2015 Apr; 58(4):222-9. PubMed ID: 25724586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing body myopathy associated with the LIM2 p.(His123Arg) FHL1 variant.
    Darki L; Jalali-Sohi A; Guzman S; Mathew AJ; Bucelli RC; Hurth KM; Beydoun SR
    Clin Neurol Neurosurg; 2021 Aug; 207():106795. PubMed ID: 34273663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rigid spine syndrome caused by a novel mutation in four-and-a-half LIM domain 1 gene (FHL1).
    Shalaby S; Hayashi YK; Goto K; Ogawa M; Nonaka I; Noguchi S; Nishino I
    Neuromuscul Disord; 2008 Dec; 18(12):959-61. PubMed ID: 18952429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolated X-linked hypertrophic cardiomyopathy caused by a novel mutation of the four-and-a-half LIM domain 1 gene.
    Hartmannova H; Kubanek M; Sramko M; Piherova L; Noskova L; Hodanova K; Stranecky V; Pristoupilova A; Sovova J; Marek T; Maluskova J; Ridzon P; Kautzner J; Hulkova H; Kmoch S
    Circ Cardiovasc Genet; 2013 Dec; 6(6):543-51. PubMed ID: 24114807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Muscle death participates in myofibrillar abnormalities in FHL1 knockout mice.
    Ding J; Cong Y; Li F; Liu B; Wu D; Miao J; Wang L
    Biochem Biophys Res Commun; 2020 Feb; 523(1):105-111. PubMed ID: 31836140
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myofibrillar myopathy caused by a novel FHL1 mutation presenting a mild myopathy with ankle contracture.
    Park YE; Kim DS; Shin JH
    Clin Neurol Neurosurg; 2019 May; 180():48-51. PubMed ID: 30928807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.